Prudent cognition of FDA announcement on the transvaginal surgical mesh treatment for pelvic organ prolapseXIE Bing, WANG Jian-liu917-920
Understanding and recognition of complications of transvaginal mesh surgeryZHAO Ying, XIA Zhi-jun920-924
Application prospect in substitute for the treatment of pelvic floor dysfunctionLIU Juan, CHEN Shuo-zhen927-930
Comparison of clinical effect between transvaginal mesh and vaginal native tissue repair in the treatment of pelvic organ prolapseLU Yong-xian930-935
Discussion on causes of erosion and exposure of transvaginal meshLIU Dong-xia, CHEN Fei, JIN Yu-xi, WANG Lu-wen938-942
Advantage and disadvantage of the application of transvaginal mesh in the perspective of big dataSUN Zhi-jing, GUO Tao945-948
Risks factors of histological chorioamnionitis after preterm premature rupture of membranes and the establishment of prediction modelHE Yuan-min, XIAO Yun-shan, GUO Xiao-jun, HUANG Shi-ting, ZHANG Xue-qin971-975